These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18461324)

  • 1. Metastatic behaviour of giant cell tumour of the spine.
    Donthineni R; Boriani L; Ofluoglu O; Bandiera S
    Int Orthop; 2009 Apr; 33(2):497-501. PubMed ID: 18461324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
    Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Giant cell tumor of bone. An evaluation of 87 patients].
    Tunn PU; Schlag PM
    Z Orthop Ihre Grenzgeb; 2003; 141(6):690-8. PubMed ID: 14679436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
    Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
    Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.
    van der Heijden L; van de Sande MA; Dijkstra PD
    Acta Orthop; 2012 Aug; 83(4):401-5. PubMed ID: 22880716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell tumor of bone with pulmonary metastases.
    Okamoto Y; Mathew S; Daw NC; Neel MD; McCarville MB; Dome JS; Hill DA
    Med Pediatr Oncol; 2003 Nov; 41(5):454-9. PubMed ID: 14515387
    [No Abstract]   [Full Text] [Related]  

  • 7. Histologically verified lung metastases in benign giant cell tumours--14 cases from a single institution.
    Dominkus M; Ruggieri P; Bertoni F; Briccoli A; Picci P; Rocca M; Mercuri M
    Int Orthop; 2006 Dec; 30(6):499-504. PubMed ID: 16909252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell tumor of bone: risk factors for recurrence.
    Klenke FM; Wenger DE; Inwards CY; Rose PS; Sim FH
    Clin Orthop Relat Res; 2011 Feb; 469(2):591-9. PubMed ID: 20706812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of giant-cell tumor of the pelvis.
    Sanjay BK; Frassica FJ; Frassica DA; Unni KK; McLeod RA; Sim FH
    J Bone Joint Surg Am; 1993 Oct; 75(10):1466-75. PubMed ID: 8408135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for pulmonary metastases from giant cell tumor of bone.
    Chan CM; Adler Z; Reith JD; Gibbs CP
    J Bone Joint Surg Am; 2015 Mar; 97(5):420-8. PubMed ID: 25740033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
    Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary metastases of giant cell tumour of the bone.
    Faisham WI; Zulmi W; Saim AH; Biswal BM
    Med J Malaysia; 2004 Dec; 59 Suppl F():78-81. PubMed ID: 15941172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aneurysmal bone cyst secondary to giant cell tumor of the mobile spine: a report of 11 cases.
    Wu Z; Yang X; Xiao J; Feng D; Huang Q; Zheng W; Huang W; Zhou Z
    Spine (Phila Pa 1976); 2011 Oct; 36(21):E1385-90. PubMed ID: 21221054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent primary giant cell tumour of the proximal radius with pulmonary metastases.
    Ropars M; Siret P; Kaila R; Duval H; Dréano T
    Joint Bone Spine; 2008 Dec; 75(6):740-1. PubMed ID: 18619891
    [No Abstract]   [Full Text] [Related]  

  • 15. Giant cell tumor of femur with single pulmonary metastasis - yet another curative oligometastasis.
    Abraham AP; Kingsley PA; Negi P; Bedi HS
    J Cancer Res Ther; 2024 Apr; 20(3):1085-1087. PubMed ID: 39023622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
    Agarwal MG; Gundavda MK; Gupta R; Reddy R
    Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
    Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
    World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of benign giant cell tumours of bone in Singapore.
    Lim YW; Tan MH
    Ann Acad Med Singap; 2005 Apr; 34(3):235-7. PubMed ID: 15902343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of adjuvants on local recurrence rate in giant cell tumour of the bone.
    Pietschmann MF; Dietz RA; Utzschneider S; Baur-Melnyk A; Jansson V; Dürr HR
    Acta Chir Belg; 2010; 110(6):584-9. PubMed ID: 21337837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up.
    Siebenrock KA; Unni KK; Rock MG
    J Bone Joint Surg Br; 1998 Jan; 80(1):43-7. PubMed ID: 9460951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.